Menu
Back to Journals » Nanotechnology, Science and Applications » Volume 1
Gold nanoparticles: From nanomedicine to nanosensing
Authors Chen PC, Mwakwari SC, Oyelere AK
Published 2 November 2008 Volume 2008:1 Pages 45—66
DOI https://doi.org/10.2147/NSA.S3707
Review by Single anonymous peer review
Peer reviewer comments 3
Po C Chen, Sandra C Mwakwari, Adegboyega K Oyelere
School of Chemistry and Biochemistry, Parker H Petit Institute for Bioengineering and Bioscience, Atlanta, GA, USA
Abstract: Because of their photo-optical distinctiveness and biocompatibility, gold nanoparticles (AuNPs) have proven to be powerful tools in various nanomedicinal and nanomedical applications. In this review article, we discuss recent advances in the application of AuNPs in diagnostic imaging, biosensing and binary cancer therapeutic techniques. We also provide an eclectic collection of AuNPs delivery strategies, including assorted classes of delivery vehicles, which are showing great promise in specific targeting of AuNPs to diseased tissues. However, successful clinical implementations of the promised applications of AuNPs are still hampered by many barriers. In particular, more still needs to be done regarding our understanding of the pharmacokinetics and toxicological profiles of AuNPs and AuNPs-conjugates.
Keywords: gold nanoparticles (AuNPs), targeted delivery, receptor-mediated endocytosis (RME), near infrared (NIR), surface plasmon resonance (SPR), surface-enhanced Raman scattering (SERS), bioimaging, biosensing, photothermal therapy
© 2008 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.